Thermo Fisher Scientific Statistics

Total Valuation

FRA:TN8 has a market cap or net worth of EUR 128.66 billion. The enterprise value is 153.32 billion.

Market Cap	128.66B
Enterprise Value	153.32B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	Jun 13, 2025

Share Statistics

Current Share Class	377.49M
Shares Outstanding	n/a
Shares Change (YoY)	-1.36%
Shares Change (QoQ)	-1.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	376.69M

Valuation Ratios

The trailing PE ratio is 21.39 and the forward PE ratio is 17.47.

PE Ratio	21.39
Forward PE	17.47
PS Ratio	3.25
PB Ratio	2.82
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.75, with an EV/FCF ratio of 24.70.

EV / Earnings	25.50
EV / Sales	4.12
EV / EBITDA	15.75
EV / EBIT	22.73
EV / FCF	24.70

Financial Position

The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.69.

Current Ratio	1.77
Quick Ratio	1.20
Debt / Equity	0.69
Debt / EBITDA	3.03
Debt / FCF	5.10
Interest Coverage	5.90

Financial Efficiency

Return on equity (ROE) is 13.70% and return on invested capital (ROIC) is 5.95%.

Return on Equity (ROE)	13.70%
Return on Assets (ROA)	5.00%
Return on Invested Capital (ROIC)	5.95%
Return on Capital Employed (ROCE)	9.14%
Revenue Per Employee	316,827
Profits Per Employee	48,110
Employee Count	125,000
Asset Turnover	0.44
Inventory Turnover	4.85

Taxes

In the past 12 months, FRA:TN8 has paid 434.83 million in taxes.

Income Tax	434.83M
Effective Tax Rate	6.74%

Stock Price Statistics

The stock price has decreased by -32.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.33%
50-Day Moving Average	360.66
200-Day Moving Average	473.50
Relative Strength Index (RSI)	47.03
Average Volume (20 Days)	121

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.77

Income Statement

In the last 12 months, FRA:TN8 had revenue of EUR 39.60 billion and earned 6.01 billion in profits. Earnings per share was 15.75.

Revenue	39.60B
Gross Profit	16.41B
Operating Income	7.25B
Pretax Income	6.45B
Net Income	6.01B
EBITDA	9.99B
EBIT	7.25B
Earnings Per Share (EPS)	15.75

Full Income Statement

Balance Sheet

The company has 5.49 billion in cash and 31.63 billion in debt, giving a net cash position of -26.14 billion.

Cash & Cash Equivalents	5.49B
Total Debt	31.63B
Net Cash	-26.14B
Net Cash Per Share	n/a
Equity (Book Value)	45.68B
Book Value Per Share	120.79
Working Capital	9.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.51 billion and capital expenditures -1.31 billion, giving a free cash flow of 6.21 billion.

Operating Cash Flow	7.51B
Capital Expenditures	-1.31B
Free Cash Flow	6.21B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 41.44%, with operating and profit margins of 18.30% and 15.18%.

Gross Margin	41.44%
Operating Margin	18.30%
Pretax Margin	16.29%
Profit Margin	15.18%
EBITDA Margin	25.24%
EBIT Margin	18.30%
FCF Margin	15.67%

Dividends & Yields

This stock pays an annual dividend of 1.49, which amounts to a dividend yield of 0.43%.

Dividend Per Share	1.49
Dividend Yield	0.43%
Dividend Growth (YoY)	9.04%
Years of Dividend Growth	7
Payout Ratio	9.48%
Buyback Yield	1.36%
Shareholder Yield	1.78%
Earnings Yield	4.67%
FCF Yield	4.82%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:TN8 has an Altman Z-Score of 4.2 and a Piotroski F-Score of 6.

Altman Z-Score	4.2
Piotroski F-Score	6